{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:09:18Z","timestamp":1791234558629,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002657","name":"Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004006","name":"Istanbul University Scientific Research Projects Unit","doi-asserted-by":"publisher","award":["TYL-2019-33725"],"award-info":[{"award-number":["TYL-2019-33725"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.thromres.2025.109407","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T06:44:19Z","timestamp":1753425859000},"page":"109407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["JAK2V617F-positive extracellular genomic materials drive endothelial inflammation and thrombosis in myeloproliferative neoplasms"],"prefix":"10.1016","volume":"253","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2882-3351","authenticated-orcid":false,"given":"Selin Fulya","family":"Toprak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6650-8307","authenticated-orcid":false,"given":"Cemal \u00c7a\u011f\u0131l","family":"Ko\u00e7ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4884-5298","authenticated-orcid":false,"given":"Esra Nur","family":"Demirta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7089-3777","authenticated-orcid":false,"given":"G\u00fcl\u015fah","family":"Tuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4210-7290","authenticated-orcid":false,"given":"\u0130ldeniz","family":"Uslu-B\u0131\u00e7ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4967-6699","authenticated-orcid":false,"given":"B\u00fc\u015fra","family":"Ya\u015fa-\u00c7evik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-4048","authenticated-orcid":false,"given":"Sel\u00e7uk","family":"S\u00f6zer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 Suppl 1","key":"10.1016\/j.thromres.2025.109407_bb0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbmt.2006.11.003","article-title":"Philadelphia chromosome-negative myeloproliferative disorders: biology and treatment","volume":"13","author":"Hoffman","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.thromres.2025.109407_bb0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41408-024-01169-6","article-title":"Thrombosis in myeloproliferative neoplasms: a viewpoint on its impact on myelofibrosis, mortality, and solid tumors","volume":"14","author":"Barbui","year":"2024","journal-title":"Blood Cancer J."},{"issue":"03","key":"10.1016\/j.thromres.2025.109407_bb0015","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0034-1370794","article-title":"Thrombosis in myeloproliferative neoplasms","volume":"40","author":"Falanga","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"issue":"15","key":"10.1016\/j.thromres.2025.109407_bb0020","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","article-title":"Classification and personalized prognosis in myeloproliferative neoplasms","volume":"379","author":"Grinfeld","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.thromres.2025.109407_bb0025","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bjhh.2014.10.001","article-title":"Myeloproliferative neoplasms and the JAK\/STAT signaling pathway: an overview","volume":"37","author":"de Freitas","year":"2015","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"8","key":"10.1016\/j.thromres.2025.109407_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080854","article-title":"Roles of JAK2 in aging, inflammation, hematopoiesis and malignant transformation","volume":"8","author":"Perner","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.thromres.2025.109407_bb0035","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jtha.2023.01.027","article-title":"JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte\u2013endothelial proadhesive interactions","volume":"21","author":"Beckman","year":"2023","journal-title":"J. Thromb. Haemost."},{"issue":"21","key":"10.1016\/j.thromres.2025.109407_bb0040","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1182\/blood-2008-11-191544","article-title":"The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome","volume":"113","author":"Sozer","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2025.109407_bb0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4274\/tjh.galenos.2022.2022.0343","article-title":"Circulating CD133(+\/\u2212) CD34(\u2212) progenitors have increased c-MYC expressions in myeloproliferative neoplasms","volume":"40","author":"Uslu B\u0131\u00e7ak","year":"2022","journal-title":"Turk J. Haematol."},{"issue":"11","key":"10.1016\/j.thromres.2025.109407_bb0050","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.3324\/haematol.2021.278499","article-title":"The possible role of mutated endothelial cells in myeloproliferative neoplasms","volume":"106","author":"Farina","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2025.109407_bb0055","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bcmd.2009.08.005","article-title":"Human CD34+ cells are capable of generating normal and JAK2V617F positive endothelial like cells in vivo","volume":"43","author":"Sozer","year":"2009","journal-title":"Blood Cells Mol. Dis."},{"issue":"4","key":"10.1016\/j.thromres.2025.109407_bb0060","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/CIRCRESAHA.118.313237","article-title":"Emerging roles of vascular endothelium in metabolic homeostasis","volume":"123","author":"Pi","year":"2018","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.thromres.2025.109407_bb0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00281-011-0285-5","article-title":"Endothelium\u2014role in regulation of coagulation and inflammation","volume":"34","author":"van Hinsbergh","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.thromres.2025.109407_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/128436","article-title":"Bone marrow vascular niche: home for hematopoietic stem cells","volume":"2014","author":"He","year":"2014","journal-title":"Bone Marrow Res."},{"key":"10.1016\/j.thromres.2025.109407_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.635189","article-title":"The dynamic Interface between the bone marrow vascular niche and hematopoietic stem cells in myeloid malignancy","volume":"9","author":"Mosteo","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.thromres.2025.109407_bb0080","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.1312148111","article-title":"JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms","volume":"111","author":"Etheridge","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.thromres.2025.109407_bb0085","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1055\/s-0038-1667015","article-title":"Endothelial cells harbouring the JAK2V617F mutation display pro-adherent and pro-thrombotic features","volume":"118","author":"Guadall","year":"2018","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109407_bb0090","first-page":"70","article-title":"Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression","volume":"104","author":"Alexandre","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2025.109407_bb0095","series-title":"Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis","author":"De Moner","year":"2025"},{"issue":"3","key":"10.1016\/j.thromres.2025.109407_bb0100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00277-016-2890-9","article-title":"Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations","volume":"96","author":"Lekovic","year":"2017","journal-title":"Ann. Hematol."},{"issue":"12","key":"10.1016\/j.thromres.2025.109407_bb0105","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1111\/jth.15095","article-title":"Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm","volume":"18","author":"Castiglione","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109407_bb0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cancergen.2020.12.006","article-title":"Extracellular genetic materials and their application in clinical practice","volume":"252-253","author":"Kocana","year":"2021","journal-title":"Cancer Genet."},{"issue":"1","key":"10.1016\/j.thromres.2025.109407_bb0115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41398-023-02549-5","article-title":"The role of extracellular genomic materials (EGMs) in psychiatric disorders","volume":"13","author":"Kurtulmus","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.thromres.2025.109407_bb0120","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41419-020-02803-4","article-title":"Bioactive DNA from extracellular vesicles and particles","volume":"11","author":"Malkin","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.thromres.2025.109407_bb0125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s40364-024-00661-2","article-title":"The detection, biological function, and liquid biopsy application of extracellular vesicle-associated DNA","volume":"12","author":"Guo","year":"2024","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.thromres.2025.109407_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-012-9839-0","article-title":"Extracellular vesicles as an emerging mechanism of cell-to-cell communication","volume":"44","author":"Tetta","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.thromres.2025.109407_bb0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: biogenesis, biologic function and clinical potential","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"issue":"5","key":"10.1016\/j.thromres.2025.109407_bb0140","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1172\/JCI124566","article-title":"Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm","volume":"130","author":"Poisson","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.thromres.2025.109407_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4274\/tjh.galenos.2021.2021.0607","article-title":"JAK2V617F-positive endothelial cells induce apoptosis and release JAK2V617F-positive microparticles","volume":"39","author":"Hekimoglu","year":"2022","journal-title":"Turk. J. Haematol."},{"key":"10.1016\/j.thromres.2025.109407_bb0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semcancer.2021.03.032","article-title":"Exosomes and extracellular vesicles: rethinking the essential values in cancer biology","volume":"74","author":"Yokoi","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"12","key":"10.1016\/j.thromres.2025.109407_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123429","article-title":"Emerging role of extracellular vesicles and cellular communication in metastasis","volume":"10","author":"Forder","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.thromres.2025.109407_bb0160","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"17","key":"10.1016\/j.thromres.2025.109407_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713316","article-title":"Significance of the cGAS-STING pathway in health and disease","volume":"24","author":"Zhou","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.thromres.2025.109407_bb0170","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/1753425915606525","article-title":"Vascular endothelial cell Toll-like receptor pathways in sepsis","volume":"21","author":"Khakpour","year":"2015","journal-title":"Innate Immun."},{"issue":"9","key":"10.1016\/j.thromres.2025.109407_bb0175","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41581-022-00589-6","article-title":"Role of the cGAS-STING pathway in systemic and organ-specific diseases","volume":"18","author":"Skopelja-Gardner","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109407_bb0180","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-021-00554-y","article-title":"Cytosolic DNA sensing by cGAS: regulation, function, and human diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.thromres.2025.109407_bb0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.hoc.2020.11.003","article-title":"The microenvironment in myeloproliferative neoplasms","volume":"35","author":"Ramanathan","year":"2021","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"3","key":"10.1016\/j.thromres.2025.109407_bb0190","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1083\/jcb.200304135","article-title":"Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation","volume":"164","author":"Palumbo","year":"2004","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109407_bb0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","article-title":"The mechanism of HMGB1 secretion and release","volume":"54","author":"Chen","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"9","key":"10.1016\/j.thromres.2025.109407_bb0200","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.20120189","article-title":"Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release","volume":"209","author":"Venereau","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.thromres.2025.109407_bb0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1749-6632.2001.tb03895.x","article-title":"Functionality of circulating DNA: the hypothesis of genometastasis","volume":"945","author":"Garcia-Olmo","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2025.109407_bb0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10238-023-01278-9","article-title":"Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?","volume":"24","author":"Witz","year":"2024","journal-title":"Clin. Exp. Med."},{"issue":"8","key":"10.1016\/j.thromres.2025.109407_bb0215","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/15384047.2018.1450120","article-title":"JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: implications for early diagnosis","volume":"19","author":"Choi","year":"2018","journal-title":"Cancer Biol. Ther."},{"issue":"12","key":"10.1016\/j.thromres.2025.109407_bb0220","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.annonc.2022.09.150","article-title":"The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer","volume":"33","author":"Berchuck","year":"2022","journal-title":"Ann. Oncol."},{"issue":"14","key":"10.1016\/j.thromres.2025.109407_bb0225","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.2169\/internalmedicine.2837-23","article-title":"Detection of the JAK2 V617F mutation in urinary cell-free DNA in patients with myeloproliferative neoplasms","volume":"63","author":"Hosoi","year":"2024","journal-title":"Intern. Med."},{"issue":"13","key":"10.1016\/j.thromres.2025.109407_bb0230","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1158\/0008-5472.CAN-07-0572","article-title":"Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis","volume":"67","author":"Shi","year":"2007","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.thromres.2025.109407_bb0235","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5551\/jat.RV17059","article-title":"Emerging roles of the innate immune system regulated by DNA sensors in the development of vascular and metabolic diseases","volume":"29","author":"Fukuda","year":"2022","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.thromres.2025.109407_bb0240","first-page":"12","article-title":"Regulation of cGAS\/STING signaling and corresponding immune escape strategies of viruses. Frontiers in cellular and infection","author":"Ge","year":"2022","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.thromres.2025.109407_bb0245","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","article-title":"The mechanism of HMGB1 secretion and release","volume":"54","author":"Chen","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"1\u20132","key":"10.1016\/j.thromres.2025.109407_bb0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbagrm.2009.09.008","article-title":"HMGB proteins: interactions with DNA and chromatin","volume":"1799","author":"Stros","year":"2010","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:28:32Z","timestamp":1761406112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825001574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":50,"alternative-id":["S0049384825001574"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109407","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JAK2V617F-positive extracellular genomic materials drive endothelial inflammation and thrombosis in myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109407"}}